A new Korean Research Investment for Global Health Technology (RIGHT) Fund to advance innovative neglected-disease technologies.

In 2018, the government of the Republic of Korea (ROK), South Korean life science companies, and a group of international funders led by the Bill & Melinda Gates Foundation launched a new and innovative funding agency to support neglected-disease research and development (R&D). The new ventu...

Full description

Bibliographic Details
Published in:PLOS Neglected Tropical Diseases
Main Authors: Peter J Hotez, Kim Bush, Andrin Oswald, Glenn Rockman, In-Taek Lim, Youngmee Jee, Chang Jin Moon, Jerome H Kim, Younbeen Kim
Format: Article in Journal/Newspaper
Language:English
Published: Public Library of Science (PLoS) 2020
Subjects:
Online Access:https://doi.org/10.1371/journal.pntd.0007956
https://doaj.org/article/0779cbbd75084296bc5e136c5dc30eb3
Description
Summary:In 2018, the government of the Republic of Korea (ROK), South Korean life science companies, and a group of international funders led by the Bill & Melinda Gates Foundation launched a new and innovative funding agency to support neglected-disease research and development (R&D). The new venture is known as the Research Investment for Global Health Technology (RIGHT) Fund.